Investigators used previous trial data to compare patients receiving the chimeric antigen receptor (CAR) T-cell therapy ...

Acute myeloid leukemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making ...

The well-studied NF-κB signaling system is a key mediator of the inflammatory response. Large-scale sequencing studies in ...

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will present new clinical data from three cornerstone hematology assets at the European Hematology Association ...

This study assesses the intracranial efficacy and overall survival (OS) benefits of 80 mg once daily osimertinib in patients with leptomeningeal metastases from epidermal growth factor receptor (EGFR) ...

Additionally, ongoing clinical trials of Bruton’s tyrosine kinase (BTK) inhibitors were identified through the ClinicalTrials.gov website in November 2023 and updated in March 2025. Results: Microglia ...